Conference Coverage: ASCO GI 2023 Highlights

Expert perspectives and strategic insights on the latest therapeutic developments in GI cancer treatment from the 2023 ASCO GI Cancers Symposium, and implications on individualized clinical decision-making.

January 25, 2023
Purchase Report

Faculty Chair

John Marshall, MD

Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Faculty Members

Tanios Bekaii-Saab, MD, FACP
Mayo Clinic, Phoenix, AZ, USA

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Reetu Mukherji, MD
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Sunnie Kim, MD
University of Colorado Comprehensive Cancer Center, Aurora, CO, USA

Manish A. Shah, MD
Weill Cornell Medicine, New York, NY, USA

Michael A. Morse, MD, FACP
Duke Cancer Center, Durham, NC, USA

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

A report will be produced that is based on the meeting, and will discuss the following topics

  • Metastatic Colorectal Cancer – Targeted Therapy  
  • Metastatic Colorectal Cancer – Immunotherapy 
  • Hepatocellular Carcinoma
  • Gastric and Gastroesophageal Junction (GEJ) Cancers 
  • Pancreatic Cancer and Biliary Tract Cancer  

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.